Evaluate the effectiveness of pharmaceutical therapies including clinical, humanistic, and pharmacoeconomic outcomes.
Develop longitudinal datasets of patients with chronic diseases that can be utilized for conducting research on treatment interventions and disease state modeling.
Implement drug utilization programs and measure their impact on physician prescribing practices, patient outcomes, and health care costs.
Develop and evaluate methods to improve the medication use process, reduce medication errors, and improve patient safety.
Develop and validate models to identify patients at risk for adverse drug events.
Recent Publications:
Kane-Gill SL. Olsen KM. Rebuck JA. Rea RS. Boatwright DW. Smythe MA. Walker TR. Lager SL. Hodgman T. Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients.Ann Pharmacotherapy 2007; 41(4):549-55.
Kane-Gill SL. Seybert AL. Lazar J. Shatzer MB. Saul MI. Kirisci L. Murali S. Resource use in decompensated heart failure by disease progression categories.Congestive Heart Failure 2007;13(1):22-8.
LeBlanc JM. Kane-Gill SL. Cook CH. Dasta JF. Bispectral index does not correlate with the stress response in critical care patients. Anesthesia & Analgesia 2007; 104(6):1616.
Watson K. Seybert AL. Saul MI. Lee JS. Kane-Gill SL. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. Pharmacotherapy. 2007;27(5):647-56.
Rea RS. Donihi AC. Bobeck M. Herout P. McKaveney TP. Kane-GillSL. Korytkowski MT. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health-System Pharm 2007;64(4):385-95.
Coley KC, Saul MI, Seybert A. Economic burden of not recognizing panic disorder in the emergency department. J Emerg Med 2007. Oct 12. Epub.
Angalakuditi M, Coley KC, Kirisci L, Saul MI, Painter L. Association between in-hospital falls and chronic disease, drug use, and anemia: A matched case-control study. J Patient Saf 2007;3:16-21.
Angalakuditi M, Coley KC. Impact of drug use and comorbidities on in-hospital falls in patients with chronic kidney disease. Ann Pharmacother 2007;41:1638-43.
Tortorici MA. Skledar SJ. Zemaitis MA. WeberRJ. Smith RB. Kroboth PD. Poloyac SM. A model for supporting and training clinical pharmaceutical scientist PhD students. American Journal of Pharmaceutical Education 2007;71(2):32.
Johnson HJ. Romano MJ. WeberRJ. Developing an integrated pharmacy service in a specialized Italian hospital. Am J Health-System Pharm 2007; 64(4):430-5.
